These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1866715)

  • 1. Phospholipase C mediated inhibition of factor VII requires triglyceride-rich lipoproteins.
    Hubbard AR; Parr LJ
    Thromb Res; 1991 May; 62(4):335-44. PubMed ID: 1866715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of phospholipase C on plasma factor VII.
    Hubbard AR; Parr LJ
    Br J Haematol; 1989 Nov; 73(3):360-4. PubMed ID: 2513868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of factor VIIa, factor XIIa and beta2-glycoprotein-1 with triglyceride-rich lipoproteins in normolipidaemic subjects.
    Cardigan RA; Donohoe S; Purdy G; Mackie IJ; Machin SJ
    Blood Coagul Fibrinolysis; 1998 Jun; 9(4):323-32. PubMed ID: 9690803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity.
    Carvalho de Sousa J; Bruckert E; Giral P; Soria C; Chapman J; Truffert J; Dairou F; De Gennes JL; Caen JP
    Haemostasis; 1989; 19(3):125-30. PubMed ID: 2744628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between coagulation factors VII and X with triglyceride rich lipoproteins.
    de Sousa JC; Soria C; Ayrault-Jarrier M; Pastier D; Bruckert E; Amiral J; Bereziat G; Caen JP
    J Clin Pathol; 1988 Sep; 41(9):940-4. PubMed ID: 3056986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triglyceride dependence of factor VII coagulant activity in deep venous thrombosis.
    Mukherjee M; Dawson G; Sembhi K; Kakkar VV
    Thromb Haemost; 1996 Oct; 76(4):500-1. PubMed ID: 8902984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the tissue factor-factor VII complex: involvement of factor Xa and lipoproteins.
    Hubbard AR; Jennings CA
    Thromb Res; 1987 May; 46(4):527-37. PubMed ID: 3617011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipase C sensitive FVII activity and FVII antigen in hypertriglyceridemia.
    Carvalho de Sousa J; Bruckert E; Soria C; Caen JP
    Nouv Rev Fr Hematol (1978); 1989; 31(1):13-5. PubMed ID: 2915918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor VII and extrinsic pathway inhibitor in acute coronary disease.
    Sandset PM; Sirnes PA; Abildgaard U
    Br J Haematol; 1989 Jul; 72(3):391-6. PubMed ID: 2788454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidemia: a clinical and laboratory study.
    Carvalho de Sousa J; Bruckert E; Giral P; Soria C; Truffert J; Mirshahi MC; de Gennes JL; Caen JP
    Haemostasis; 1989; 19(2):83-90. PubMed ID: 2731779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial effects of an oleic acid-rich oil compared with butter on clotting factor VII and fibrinolysis in healthy men.
    Oakley FR; Sanders TA; Miller GJ
    Am J Clin Nutr; 1998 Dec; 68(6):1202-7. PubMed ID: 9846847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activation of factor VII in citrated plasma by charged long-chain saturated fatty acids at the interface of large triglyceride-rich lipoproteins.
    Mitropoulos KA; Reeves BE; Miller GJ
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):943-51. PubMed ID: 8148488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma level of triglyceride-rich lipoprotein remnants is closely associated with the activation of coagulation factor VII in patients with myocardial infarction.
    Saigo M; Abe S; Ogawa M; Biro S; Minagoe S; Maruyama I; Toda H; Kiyonaga K; Atsuchi Y; Tahara M; Mawatari K; Tei C
    Thromb Res; 2000 Oct; 100(1):9-17. PubMed ID: 11053611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum phospholipids are the main environmental determinants of activated factor VII in the most common FVII genotype. European Union Concerted Action "Clotart".
    Mariani G; Bernardi F; Bertina R; Vicente VV; Prydz H; Samama M; Sandset PM; Di Nucci GD; Testa MG; Bendz B; Chiarotti F; Ciarla MV; Strom R
    Haematologica; 1999 Jul; 84(7):620-6. PubMed ID: 10406904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractionation of plasma triglyceride-rich lipoproteins of the dairy cow: evidence of chylomicron-size particles.
    Ferreri LF; Elbein RC
    J Dairy Sci; 1982 Oct; 65(10):1912-20. PubMed ID: 7174960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII: a study in familial lipoprotein-lipase deficiency.
    Mitropoulos KA; Miller GJ; Watts GF; Durrington PN
    Atherosclerosis; 1992 Aug; 95(2-3):119-25. PubMed ID: 1418087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasma.
    Skartlien AH; Lyberg-Beckmann S; Holme I; Hjermann I; Prydz H
    Arteriosclerosis; 1989; 9(6):798-801. PubMed ID: 2686604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation factor VII, serum-triglycerides and the R/Q353 polymorphism: differences between older men and women.
    Mennen LI; de Maat MP; Schouten EG; Kluft C; de Jong PT; Hofman A; Grobbee DE
    Thromb Haemost; 1997 Sep; 78(3):984-6. PubMed ID: 9308739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins.
    Zilversmit DB
    Clin Chem; 1995 Jan; 41(1):153-8. PubMed ID: 7813071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tissue thromboplastin-mediated blood coagulation.
    Hubbard AR; Jennings CA
    Thromb Res; 1986 May; 42(4):489-98. PubMed ID: 3087014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.